Rimantadine: Difference between revisions
Gerald Chi (talk | contribs) m (Changed protection level for "Rimantadine" ([Edit=Allow only autoconfirmed users] (expires 16:28, 14 January 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 16:28, 14 January 2014 (UTC)))) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Rimantadine}} | |||
{{CMG}} | |||
==Overview== | |||
'''Rimantadine''' ([[International Nonproprietary Name|INN]], sold under the trade name '''Flumadine''') is an orally administered [[antiviral drug]]used to treat, and in rare cases prevent, [[Influenzavirus A]] infection. When taken within one to two days of developing symptoms, rimantadine can shorten the duration and moderate the severity of influenza. It is a derivate of [[adamantane]], like a similar drug [[amantadine]]. It was approved by the [[Food and Drug Administration]] (FDA) in 1994. | |||
==Category== | |||
Antiviral | |||
==US Brand Names== | |||
Flumadine<sup>®</sup> | |||
==FDA Package Insert== | |||
'''Rimantadine''' | ''' [[Rimantadine description|Description]]''' | ||
'''| [[Rimantadine clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Rimantadine microbiology|Microbiology]]''' | |||
'''| [[Rimantadine indications and usage|Indications and Usage]]''' | |||
'''| [[Rimantadine contraindications|Contraindications]]''' | |||
'''| [[Rimantadine warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Rimantadine adverse reactions|Adverse Reactions]]''' | |||
'''| [[Rimantadine drug interactions|Drug Interactions]]''' | |||
'''| [[Rimantadine overdosage|Overdosage]]''' | |||
'''| [[Rimantadine clinical studies|Clinical Studies]]''' | |||
'''| [[Rimantadine dosage and administration|Dosage and Administration]]''' | |||
'''| [[Rimantadine how supplied|How Supplied]]''' | |||
'''| [[Rimantadine labels and packages|Labels and Packages]]''' | |||
== | ==Mechanism of Action== | ||
==References== | |||
{{Reflist|2}} | |||
[[Category:Antiviral]] | |||
[[Category:Wikinfect]] | |||
[[Category: | |||
[[Category: |
Revision as of 19:44, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Rimantadine (INN, sold under the trade name Flumadine) is an orally administered antiviral drugused to treat, and in rare cases prevent, Influenzavirus A infection. When taken within one to two days of developing symptoms, rimantadine can shorten the duration and moderate the severity of influenza. It is a derivate of adamantane, like a similar drug amantadine. It was approved by the Food and Drug Administration (FDA) in 1994.
Category
Antiviral
US Brand Names
Flumadine®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages